JiangSu WuZhong Pharmaceutical Development Co Ltd
SSE:600200
Intrinsic Value
Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. engages in the research and development, production and sales of pharmaceuticals, organic pigments, dyes and their intermediates. [ Read More ]
The intrinsic value of one
JiangSu WuZhong Pharmaceutical Development Co Ltd
stock under the Base Case scenario is
8.91
CNY.
Compared to the current market price of 10.36 CNY,
JiangSu WuZhong Pharmaceutical Development Co Ltd
is
Overvalued by 14%.
JiangSu WuZhong Pharmaceutical Development Co Ltd's market capitalization is 7.3B CNY.
JiangSu WuZhong Pharmaceutical Development Co Ltd stock price is 10.36 CNY.
JiangSu WuZhong Pharmaceutical Development Co Ltd stock (8.91 CNY) is 14% less than its price (10.36 CNY).
JiangSu WuZhong Pharmaceutical Development Co Ltd stock price (10.36 CNY) is 5% less than its DCF Value (10.86 CNY). Open DCF Valuation
JiangSu WuZhong Pharmaceutical Development Co Ltd stock (6.96 CNY) is 33% less than its price (10.36 CNY). Open Relative Valuation
JiangSu WuZhong Pharmaceutical Development Co Ltd has upside potential of 25% compared to the average analyst price target.
Open Wall St Estimates
JiangSu WuZhong Pharmaceutical Development Co Ltd's Revenue has been growing by 1% per year for the last 3 years.
JiangSu WuZhong Pharmaceutical Development Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.95.
JiangSu WuZhong Pharmaceutical Development Co Ltd's short-term assets (3B CNY) exceed its short-term liabilties (2B CNY).
JiangSu WuZhong Pharmaceutical Development Co Ltd's Revenue has grown by an exceptional 27% over the past 12 months.
JiangSu WuZhong Pharmaceutical Development Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 1%.
JiangSu WuZhong Pharmaceutical Development Co Ltd has positive Net Debt. This means that the company has more debt (2B CNY) than cash and short-term investments (2B CNY).
JiangSu WuZhong Pharmaceutical Development Co Ltd's ROE (Return on Equity) for the past 12 months is negative and is equal to -1%.
JiangSu WuZhong Pharmaceutical Development Co Ltd's Revenue is forecast to grow at a rate of 18% per year over the next 3 years.
JiangSu WuZhong Pharmaceutical Development Co Ltd has negative Free Cash Flow for the last twelve months.
JiangSu WuZhong Pharmaceutical Development Co Ltd has positive Gross Profit for the last twelve months.
JiangSu WuZhong Pharmaceutical Development Co Ltd's long-term assets (4B CNY) exceed its long-term liabilties (2B CNY).
JiangSu WuZhong Pharmaceutical Development Co Ltd's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -17% to 1%.
JiangSu WuZhong Pharmaceutical Development Co Ltd's ROE (Return on Equity) has significantly increased in the last 3 years from -19% to -1%, and is approaching profitability.
JiangSu WuZhong Pharmaceutical Development Co Ltd's Altman Z-Score is equal to 1.96.
JiangSu WuZhong Pharmaceutical Development Co Ltd has positive Operating Income for the last twelve months.
JiangSu WuZhong Pharmaceutical Development Co Ltd has negative Net Income for the last twelve months.
JiangSu WuZhong Pharmaceutical Development Co Ltd has negative three-year average ROIC (Return on Invested Capital): -5%. The company is not efficient at using invested capital to generate operating income.
JiangSu WuZhong Pharmaceutical Development Co Ltd has negative three-year average ROE (Return on Equity): -8%. The company is not efficient at transforming stockholders' equity into net income.
Valuation Backtest
JiangSu WuZhong Pharmaceutical Development Co Ltd
Run backtest to discover the historical profit from buying and selling
JiangSu WuZhong Pharmaceutical Development Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
JiangSu WuZhong Pharmaceutical Development Co Ltd
Balance Sheet Decomposition
JiangSu WuZhong Pharmaceutical Development Co Ltd
| Current Assets | 3B |
| Cash & Short-Term Investments | 1.6B |
| Receivables | 1.2B |
| Other Current Assets | 155.9m |
| Non-Current Assets | 1.3B |
| Long-Term Investments | 797.4m |
| PP&E | 220.6m |
| Intangibles | 234.3m |
| Other Non-Current Assets | 28m |
| Current Liabilities | 2.2B |
| Accounts Payable | 210.9m |
| Accrued Liabilities | 18.7m |
| Short-Term Debt | 1.6B |
| Other Current Liabilities | 405.4m |
| Non-Current Liabilities | 193.3m |
| Long-Term Debt | 128.2m |
| Other Non-Current Liabilities | 65.2m |
Earnings Waterfall
JiangSu WuZhong Pharmaceutical Development Co Ltd
|
Revenue
|
2.1B
CNY
|
|
Cost of Revenue
|
-1.6B
CNY
|
|
Gross Profit
|
572.5m
CNY
|
|
Operating Expenses
|
-544.7m
CNY
|
|
Operating Income
|
27.8m
CNY
|
|
Other Expenses
|
-46.2m
CNY
|
|
Net Income
|
-18.4m
CNY
|
Free Cash Flow Analysis
JiangSu WuZhong Pharmaceutical Development Co Ltd
Profitability Score
Profitability Due Diligence
JiangSu WuZhong Pharmaceutical Development Co Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
Score
JiangSu WuZhong Pharmaceutical Development Co Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
JiangSu WuZhong Pharmaceutical Development Co Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
JiangSu WuZhong Pharmaceutical Development Co Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
JiangSu WuZhong Pharmaceutical Development Co Ltd
According to Wall Street analysts, the average 1-year price target for
JiangSu WuZhong Pharmaceutical Development Co Ltd
is 12.95 CNY
with a low forecast of 12.83 CNY and a high forecast of 13.34 CNY.
Shareholder Return
Price
JiangSu WuZhong Pharmaceutical Development Co Ltd
| Average Annual Return | 8.65% |
| Standard Deviation of Annual Returns | 32.99% |
| Max Drawdown | -63% |
| Market Capitalization | 7.3B CNY |
| Shares Outstanding | 712 286 016 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
JiangSu WuZhong Pharmaceutical Development Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. engages in the research and development, production and sales of pharmaceuticals, organic pigments, dyes and their intermediates. The company is headquartered in Suzhou, Jiangsu and currently employs 1,067 full-time employees. The firm's business includes pharmaceuticals, chemicals and real estate. Pharmaceutical business mainly involves pharmaceutical research, development, manufacture and sales. Chemical business mainly includes research, development, manufacture and sales of organic pigments, dyes and intermediates. Its main production varieties are used to produce reactive dyes and organic pigments. Real estate business includes commercial housing and affordable housing.
Contact
IPO
Employees
Officers
The intrinsic value of one
JiangSu WuZhong Pharmaceutical Development Co Ltd
stock under the Base Case scenario is
8.91
CNY.
Compared to the current market price of 10.36 CNY,
JiangSu WuZhong Pharmaceutical Development Co Ltd
is
Overvalued by 14%.
You don't have any saved screeners yet
